Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions.

Rough K, Bateman BT, Patorno E, Desai RJ, Park Y, Hernandez-Diaz S, Huybrechts KF.

JAMA. 2016 Mar 15;315(11):1164-6. doi: 10.1001/jama.2015.18417. No abstract available.

PMID:
26978213
2.

A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010.

Skrepnek GH, Mills JL Sr, Armstrong DG.

PLoS One. 2015 Aug 6;10(8):e0134914. doi: 10.1371/journal.pone.0134914. eCollection 2015.

3.

How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?

Hsu JC, Ross-Degnan D, Wagner AK, Zhang F, Lu CY.

Clin Ther. 2015 Jul 1;37(7):1420-1432.e1. doi: 10.1016/j.clinthera.2015.04.006. Epub 2015 May 11.

PMID:
25976425
4.

Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs.

Saine ME, Carbonari DM, Newcomb CW, Nezamzadeh MS, Haynes K, Roy JA, Cardillo S, Hennessy S, Holick CN, Esposito DB, Gallagher AM, Bhullar H, Strom BL, Lo Re V 3rd.

BMC Pharmacol Toxicol. 2015 Apr 2;16:8. doi: 10.1186/s40360-015-0007-z.

5.

Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products.

Gilligan AM, Waycaster CR, Landsman AL.

J Wound Care. 2015 Mar;24(3):149-56. doi: 10.12968/jowc.2015.24.3.149.

PMID:
25764960
6.

Effect of diabetes mellitus on giant cell arteritis.

Abel AS, Yashkin AP, Sloan FA, Lee MS.

J Neuroophthalmol. 2015 Jun;35(2):134-8. doi: 10.1097/WNO.0000000000000218.

7.

Relation between BMI and diabetes mellitus and its complications among US older adults.

Gray N, Picone G, Sloan F, Yashkin A.

South Med J. 2015 Jan;108(1):29-36. doi: 10.14423/SMJ.0000000000000214.

8.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.

PMID:
25257325
9.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296.

10.

Development of a clinical registry-based 30-day readmission measure for coronary artery bypass grafting surgery.

Shahian DM, He X, O'Brien SM, Grover FL, Jacobs JP, Edwards FH, Welke KF, Suter LG, Drye E, Shewan CM, Han L, Peterson E.

Circulation. 2014 Jul 29;130(5):399-409. doi: 10.1161/CIRCULATIONAHA.113.007541. Epub 2014 Jun 10.

11.

Prostate cancer treatment and survival: evidence for men with prevalent comorbid conditions.

Bradley CJ, Dahman B, Anscher M.

Med Care. 2014 Jun;52(6):482-9. doi: 10.1097/MLR.0000000000000113.

12.

Continuity and the costs of care for chronic disease.

Hussey PS, Schneider EC, Rudin RS, Fox DS, Lai J, Pollack CE.

JAMA Intern Med. 2014 May;174(5):742-8. doi: 10.1001/jamainternmed.2014.245.

13.

Beyond comorbidity: expanding the definition and measurement of complexity among older adults using administrative claims data.

Chrischilles E, Schneider K, Wilwert J, Lessman G, O'Donnell B, Gryzlak B, Wright K, Wallace R.

Med Care. 2014 Mar;52 Suppl 3:S75-84. doi: 10.1097/MLR.0000000000000026.

PMID:
24561763
14.

Geographic variation in statin use for complex acute myocardial infarction patients: evidence of effective care?

Brooks JM, Cook EA, Chapman CG, Kulchaitanaroaj P, Chrischilles EA, Welch S, Robinson J.

Med Care. 2014 Mar;52 Suppl 3:S37-44. doi: 10.1097/MLR.0b013e3182a7fc3d.

PMID:
24561757
15.

Heterogeneity in the quality of care for patients with multiple chronic conditions by psychiatric comorbidity.

Domino ME, Beadles CA, Lichstein JC, Farley JF, Morrissey JP, Ellis AR, Dubard CA.

Med Care. 2014 Mar;52 Suppl 3:S101-9. doi: 10.1097/MLR.0000000000000024.

PMID:
24561748
16.
17.

Increasing Medicare part D enrollment in medication therapy management could improve health and lower costs.

Stuart B, Loh FE, Roberto P, Miller LM.

Health Aff (Millwood). 2013 Jul;32(7):1212-20. doi: 10.1377/hlthaff.2012.0848.

18.

Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.

Ye X, Qian C, Liu J, St Peter WL.

Pharmacotherapy. 2013 Oct;33(10):1062-70. doi: 10.1002/phar.1317. Epub 2013 Jun 24.

19.

Hypertension and diabetes mellitus medication management in sleeve gastrectomy patients.

Bland CM, Tritsch AM, Bookstaver DA, Sweeney LB, Wiley D, Choi YU.

Am J Health Syst Pharm. 2013 Jun 15;70(12):1018-20. doi: 10.2146/ajhp120607. No abstract available.

PMID:
23719877
20.

Diabetes prevention and the role of risk factor reduction in the Medicare population.

Koller EA, Chin JS, Conway PH.

Am J Prev Med. 2013 Apr;44(4 Suppl 4):S307-16. doi: 10.1016/j.amepre.2012.12.019.

PMID:
23498292
Items per page

Supplemental Content

Loading ...
Write to the Help Desk